Combination therapies comprising quinoxaline inhibitors of PI3K-alpha for use in the treatment of cancer

Details for Australian Patent Application No. 2008239668 (hide)

Owner EXELIXIS, INC.

Inventors Matthews, David; Lamb, Peter

Agent A J Park

Pub. Number AU-A-2008239668

PCT Pub. Number WO2008/127594

Priority 60/923,164 11.04.07 US

Filing date 8 April 2008

Wipo publication date 23 October 2008

International Classifications

A61K 31/497 (2006.01)

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/436 (2006.01)

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/555 (2006.01) - containing heavy metals, e.g. hemin, hematin, melarsoprol

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

29 October 2009 PCT application entered the National Phase

  PCT publication WO2008/127594 Priority application(s): WO2008/127594

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008239670-Vaccine

2008239659-Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor